Skip to content

Ask Stanford Med: Stanford interventional cardiologist taking questions on heart health

Cardiovascular disease is the reigning cause of mortality in the United States, with heart disease and stroke accounting for 2,200 deaths per day. As a result, many of us know someone who has had cardiovascular problems, and some of us have a concern over our own risk for heart disease or stroke.

In recognition of American Heart Month, we've asked Stanford interventional cardiologist William Fearon, MD, to respond to your questions about cardiovascular research, including advancements in diagnosing, treating and preventing heart disease and stroke.

Fearon's clinical focus includes interventional cardiology, coronary artery disease and aortic stenosis, and his general research interest is coronary physiology. His recent focus is on the potential benefits of using a relatively new technology called “fractional flow reserve,” or FFR, to accurately determine which patients require artery-opening stents. In a study published last August, he and colleagues showed that FFR can be useful in identifying those patients with stable coronary artery disease who should have early placement of artery-opening stents, versus be treated solely with medical therapy, such as aspirin or statins.

Questions can be submitted to Fearon by either sending a tweet that includes the hashtag #AskSUMed or posting your question in the comments section below. We’ll collect questions until Monday (Feb.11) at 5 PM Pacific Time.

When submitting questions, please abide by the following ground rules:

  • Stay on topic
  • Be respectful to the person answering your questions
  • Be respectful to one another in submitting questions
  • Do not monopolize the conversation or post the same question repeatedly
  • Kindly ignore disrespectful or off topic comments
  • Know that Twitter handles and/or names may be used in the responses

Fearon will respond to a selection of the questions submitted, but not all of them, in a future entry on Scope.

Finally – and you may have already guessed this – an answer to any question submitted as part of this feature is meant to offer medical information, not medical advice. These answers are not a basis for any action or inaction, and they’re also not meant to replace the evaluation and determination of your doctor, who will address your specific medical needs and can make a diagnosis and give you the appropriate care.

Previously: Guidewire technology improves heart patient care, New tool for heart disease saves both lives and money, Stanford researchers describe experimental treatment for deadly heart disease, Ask Stanford Med: Cardiologist Jennifer Tremmel responds to questions on women’s heart health and Ask Stanford Med: Cardiologist Jennifer Tremmel taking questions on women’s heart health
Photo by Eva Blue

Popular posts

Category:
Biomedical research
COVID-19 can infect the inner ear

Researchers say anyone with new on-set hearing loss, tinnitus or vertigo, with exposure to COVID-19, should be tested and monitored.
Category:
Cancer
Can Prozac fight brain cancer?

The common antidepressant Prozac melts away glioblastoma tumors in laboratory mice, suggesting possible treatment for the deadly cancer.